InfuSystem Holdings, Inc. (NYSE:INFU) CFO Buys $17,280.00 in Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry G. Steele acquired 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $5.76 per share, for a total transaction of $17,280.00. Following the completion of the purchase, the chief financial officer now owns 76,887 shares of the company’s stock, valued at approximately $442,869.12. This represents a 4.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

InfuSystem Price Performance

Shares of InfuSystem stock opened at $6.15 on Friday. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $5.27 and its two-hundred day moving average price is $7.13. InfuSystem Holdings, Inc. has a 52 week low of $4.61 and a 52 week high of $9.97. The stock has a market cap of $129.25 million, a PE ratio of 102.52 and a beta of 1.73.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on INFU shares. B. Riley upgraded shares of InfuSystem to a “strong-buy” rating in a research note on Thursday, May 8th. StockNews.com cut shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. Finally, Sidoti upgraded shares of InfuSystem to a “strong-buy” rating in a research note on Tuesday, March 18th.

Hedge Funds Weigh In On InfuSystem

Institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets increased its stake in InfuSystem by 67.9% in the 4th quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company’s stock worth $58,000 after purchasing an additional 2,768 shares in the last quarter. Jump Financial LLC purchased a new position in InfuSystem in the 1st quarter worth about $58,000. Wells Fargo & Company MN increased its stake in InfuSystem by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 9,286 shares of the company’s stock worth $78,000 after purchasing an additional 3,165 shares in the last quarter. Legato Capital Management LLC purchased a new position in InfuSystem in the 4th quarter worth about $85,000. Finally, Summit Global Investments purchased a new position in InfuSystem in the 4th quarter worth about $86,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.